Medline Inc. (MDLN): Shareholders' Equity

Annual figures by period end, from SEC filings.

$10.74B

As of 2025-12-31

$11.57B

As of 2026-06-27

Period ended	Shareholders' Equity	Change YoY	Source filing
2025-12-31	$10.74B	n/a	2026-02-25, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Shareholders' Equity	Change YoY
Medline Inc. (MDLN)	2025-12-31	$10.74B	n/a
Stryker Corp (SYK)	2025-12-31	$22.42B	+8.7%
3M Co (MMM)	2025-12-31	$4.75B	+21.9%
Becton Dickinson & Co (BDX)	2025-09-30	$25.39B	-1.9%
Boston Scientific Corp (BSX)	2025-12-31	$24.47B	+11.2%
Baxter International Inc (BAX)	2025-12-31	$6.10B	-13.1%
Solventum Corp (SOLV)	2025-12-31	$5.05B	+70.6%
ResMed Inc (RMD)	2026-06-30	$6.59B	+10.3%
Dexcom Inc (DXCM)	2025-12-31	$2.75B	+30.6%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗